Emily Rosenich

Australian Regenerative Medicine Institute

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Multidomain modifiable dementia risk factors are associated with poorer cognition in midlife.”.

Multidomain modifiable dementia risk factors are associated with poorer cognition in midlife.

Neuropsychology(2023)10.1037/neu0000900

N/A

0DataRank · unranked

17 citations

Emily Rosenich, Rachel F. Buckley, Nawaf Yassi, Matthew P. Pase, Paul Maruff +2 more

Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults

Neurobiology of Aging(2024)10.1016/j.neurobiolaging.2024.02.015

N/A

0DataRank · unranked

6 citations

Nawaf Yassi, Emily Rosenich, Rachel F. Buckley, Qiao‐Xin Li, Paul Maruff +3 more

BDNF Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer’s disease

Archives of Clinical Neuropsychology(2024)10.1093/arclin/acae014

N/A

0DataRank · unranked

5 citations

Emily Rosenich, Paul Maruff, Yen Ying Lim, for the Alzheimer’s Disease Neuroimaging Initiative, Diny Thomson